TransMessenger Transfection Reagent

For efficient mRNA transfection
  • Highly efficient transfection
  • Reproducible results ensured by stringent quality control
  • Efficient transfection of primary neuronal cells
TransMessenger Transfection Reagent is a ready-to-use, lipid-based reagent for RNA transfection of eukaryotic cells. Transfection of cells with RNA rather than DNA offers new possibilities for transfection experiments. Cell lines successfully transfected with TransMessenger Reagent  include 293T, Jurkat, and Vero. This product can also be used for RNA transfection of primary human fibroblasts, rat cardiomyocytes, and rat neuronal cells.
Quantity Product Cat. no. Price
 
 
show details
  varies
Quantity Product Cat. no. Price Sum
 
TransMessenger Transfection Reagent (0.5 ml)
For 60 transfections in 6-well plates or 80 transfections in 12-well plates
301525
$212.00
$0.00
The TransMessenger Transfection Reagent is intended for molecular biology applications. This product is not intended for the diagnosis, prevention, or treatment of a disease.
  • Main Image Navi
Amount of RNA and TransMessenger Reagent vs. transfection efficiency.|TransMessenger Reagent with HeLa cells.|Cardiac cell studies.|
Optimization experiments were performed in CHO-K1 cells. Cells (2 x 104) were seeded in quadruplicate into 96-well plates and transfected 24 hours later with an in vitro-transcribed CAT-encoding RNA using [A] increasing amounts of RNA with 1.5 µl TransMessenger Reagent and [B] increasing amounts of TransMessenger Reagent with 0.25 µg RNA, as described in the TransMessenger Transfection Reagent Handbook. CAT activity was measured 24 hours post-transfection.|Expression of green fluorescence protein (GFP) in HeLa-S3 cells was examined. Cells (8 x 104) were seeded into 48-well plates and transfected 24 hours later with 0.5 µg of an in vitro-transcribed GFP-encoding RNA (transcribed from P7ASP-GFP/Mlu) using 1 µl Enhancer R and 2.5 µl TransMessenger Reagent. Cells were analyzed 24 hours post-transfection by fluorescence microscopy. Approximately 50% of the cells were successfully transfected. (P7ASP-GFP/Mlu kindly provided by J. Bogenberger, Stanford University Blood Center, Palo Alto, CA, USA.)|[A] Use of TransMessenger Transfection Reagent resulted in an excellent, 60% survival rate post-transfection with beating, functional cardiomyocytes, and a transfection efficiency of 10–13%. [B] High rate of cardiomyocyte and non-cardiomyocyte transfection. Left: Superimposed images showing anti-GFP (green; transfected cell) and anti-α-actinin (red; cardiomyocyte) staining. Right: Anti-α-actinin (cardiomyocyte) staining. Arrows = GFP-positive cardiomyocytes;* = GFP-positive non-cardiomyocytes. [C]  Left: GFP-positive cardiomyocytes (green) and non-transfected cardiomyocytes (red; stained with anti-α-actinin) demonstrate equivalent morphologies. Right: Transfected cardiomyocyte and non-cardiomyocyte cells.
Data provided by QBMCellScience Inc, Ottawa, ON. Canada|
Performance
TransMessenger Reagent provides a fast and easy procedure and high transfection efficiencies (see figure "TransMessenger Reagent with HeLa cells"). Since the amount of RNA is a critical factor for successful transfection, we recommend optimizing the amounts of RNA and TransMessenger Transfection Reagent for every cell type–RNA combination (see figure "Amount of RNA and TransMessenger Reagent vs. transfection efficiency"). To facilitate this, the reagent is provided with guidelines for optimization together with starting points for optimization in different cell-culture formats.

TransMessenger Transfection Reagent is highly suited for use in functional cardiac cell studies using neonatal rat ventricular cardiac cells.
Cardiomyocytes from cryopreserved, dissociated neonatal rat ventricular cardiac cells (R-CM-561 [QBMCellScience.com]) display excellent viability, pharmacology, morphology, and connectivity, as well as contractile and electrical activity necessary for use in functional screening (see video Transfection control: Functional Cardiomyocytes Beating). To evaluate the suitability of using TransMessenger Transfection Reagent in functional cardiac cell studies, cells were transfected with a GFP-expression vector 4 hours after plating, and were fixed 5 days post-transfection. Use of TransMessenger Transfection Reagent resulted in an excellent, 60% survival rate post-transfection with a transfection efficiency of 10–13%. All cardiomyocytes displayed beating post-transfection (sees videos GPF-Positive Cardiomyocytes Beating Post-Transfection and Functional Cardiomyocytes Beating Post-Transfection), indicating functional cells. The number of transfected cardiomyocyte verses non-cardiomyocyte cells was evaluated and results demonstrate that a high number of cardiomyocyte and non-cardiomyocyte cells were transfected. Equivalent morphologies between transfected and non-transfected cells were also observed (see figure Cardiac cell studies).
Principle
TransMessenger Transfection Reagent is the first reagent specifically developed for transfection of cells with RNA. The reagent is a lipid-based formulation that is used in conjunction with a specific RNA-condensing enhancer and an optimized buffer. RNA molecules are condensed by the enhancer and then coated by TransMessenger Reagent for efficient transfer into eukaryotic cells. Strict quality control is performed to test for absence of RNase activity, lot-to-lot consistency, and low endotoxin levels (≤10 EU/ml). Our rigorous standards eliminate reagent variables that can adversely affect the efficiency of RNA transfection.
Procedure
All TransMessenger Reagent components are provided as ready-to-use solutions. To generate TransMessenger–RNA transfection complexes, simply mix your RNA with Enhancer R and Buffer EC-R and incubate for 5 minutes at room temperature, then add TransMessenger Reagent and incubate for a further 5–10 minutes. The complexes are mixed with medium and added directly to the cells. Following a 3 hour incubation, the medium is changed and the cells are incubated until they are ready for analysis.
Optimal transfection results are achieved using high-purity RNA that is free of DNA, proteins, and other contaminants. RNA purified with RNeasy and Oligotex mRNA Kits is highly recommended.
Applications
Transfection of cells with RNA rather than DNA offers new possibilities for transfection experiments. Transfected RNA sequences are expressed in the absence of transcription, and in a promoter-independent manner. In addition, protein expression usually occurs sooner following transfection of RNA rather than DNA. 

RNA transfection with TransMessenger Transfection Reagent can be used for:
  • Studies of cells not efficiently transfected with plasmid
  • DNA Direct studies of RNA function
Feature
Specifications
Applications Direct studies of RNA function
Cell type Eukaryotic cells
Controls Not included
Features Transfection with RNA. Efficient transfection of neuronal cells.
Nucleic acid RNA
Number of possible transfections 80 transfections in 12-well plates / 0,5 ml reagent
Technology Lipid-based formulation in conjunction with a RNA-condensing enhancer
Transfection type Transient transfection, co-transfection

Transfection Protocols
2
Search for transfection data by nucleic acid, cell line, and transfection reagent. Our database contains data from researchers like yourself who have shared their experimental results with us.
View
Transfection protocols for specific cell types and plate formats that save you the time and effort of adapting existing protocols to fit your requirements. Simply select the cell type, nucleic acid, and culture format to receive a QIAGEN transfection protocol to print out or download in convenient PDF format.
View
Supplementary Protocols
1
The following procedure is for co-transfection of adherent cells using siRNA and plasmid DNA in one well of a 24-well plate. This procedure is provided as a starting point for optimization of siRNA and plasmid DNA co-transfection in mammalian cells using TransMessenger™ Transfection Reagent.
Show details